EW (Edwards Lifesciences Corporation) is set to announce its Q2'26 results on July 23, after the market closes. The earnings are expected to be disclosed at 4:00 PM ET (8:00 PM UTC).
For Q2'26, revenue estimate is 1.70 billion USD with EPS (earnings per share) anticipated at 0.74 USD. Learn more details at .
Revenue & EPS values are provided in USD
| Q2'25Q3'25Q4'25Q1'26Q2'26 | |||||
| Revenue Reported1.53 B1.55 B1.57 B1.65 B— | Revenue Estimate1.49 B1.50 B1.55 B1.60 B1.70 B | Revenue Surprise+2.97%+3.69%+1.47%+3.24% | EPS Reported0.670.670.580.78 | EPS Estimate0.620.600.620.730.74 | EPS Surprise+7.42%+12.39%-6.14%+6.98% |